Tradestie Institutional Equity Comparison Engine

NIVF vs BSLK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NIVF Overall Edge

NIVF Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NewGenIvf Group Limited Class A ordinary shares (NIVF) driven by superior Growth & Margin, Momentum & Technical while BSLK counters with relative strength in Valuation. Fundamentally, NIVF trades at N/M Forward P/E with -238.2% operating margin (-4.7% YoY revenue) versus BSLK at N/M Forward P/E and -1179.5% operating margin (+7300.0% YoY). In options structure, NIVF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BSLK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BSLK
NIVF N/M vs BSLK N/M Fwd P/E
Growth & Margin Winner NIVF
Op Margin -238.2% vs -1179.5% ยท YoY -4.7% vs +7300.0%
Momentum & Technical Winner NIVF
1Y -44.8% vs -94.4% ยท 52W Pos 5% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NIVF NASDAQ
NewGenIvf Group Limited Class A ordinary shares
Services-Misc Health & Allied Services, Nec
$0.20
-11.33% 1D
Market Cap $369,508
1M Return -26.52%
1Y Return -44.83%
Forward P/E N/M
Unified AI Score
42.4 / 100 HOLD
Tech 40.0 Fund 40.0 Flow 50.0 Mom 45.0
BSLK NASDAQ
Bolt Projects Holdings, Inc. Common Stock
Industrial Organic Chemicals
$0.58
-27.01% 1D
Market Cap $7.1M
1M Return -73.85%
1Y Return -94.42%
Forward P/E N/M
Unified AI Score
41.2 / 100 SELL
Tech 40.0 Fund 43.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NIVF -44.83% BSLK -94.42% Spread: +149.83 pp (NIVF Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NIVF Revenue BSLK Revenue NIVF Op. Margin BSLK Op. Margin Margin Edge
Q4 '24 N/A $10M N/A -504.4% BSLK
Q1 '25 N/A $0M N/A -3157.9% BSLK
Q2 '25 N/A $10M N/A -370.0% BSLK
Q3 '25 $10M $0M -195.9% -1179.5% NIVF
Q4 '25 $10M N/A -349.1% N/A NIVF

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NIVF (5) vs BSLK (3)
Institutional Metric NIVF BSLK Criterion Row Winner
Market Capitalization Scale $369,508 $7.1M Larger Scale Tie
Trailing P/E Ratio Valuation N/M 0.1x Lower Multiple BSLK
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -4.7% +7300.0% Higher Growth BSLK
Operating Margin (TTM) Profitability -238.2% -1179.5% Higher Margin NIVF
Net Profit Margin Profitability 24.2% 0.0% Higher Margin NIVF
Return on Equity (ROE) Capital Efficiency 5.5% -4288.3% Higher ROE NIVF
52-Week Range Position Momentum 5% ($0โ€“$3) 0% ($1โ€“$25) Stronger Trend NIVF
Beta / 30D Volatility Risk Regime 0.07ฮฒ ยท 3093% Vol 4.04ฮฒ ยท 148% Vol Lower Realized Risk BSLK
Unified Institutional Score Composite Signal 42.4 / 100 (HOLD) 41.2 / 100 (SELL) Higher Composite NIVF

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NIVF vs BSLK Buy Guide
NIVF UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NIVF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BSLK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BSLK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NIVF nor BSLK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.